Does RISANKIZUMAB-RZAA Cause Cognitive disorder? 45 Reports in FDA Database
Visibly Younger Skin in Weeks
Synevra Lift & Lock — Swiss peptide serum + nutrients. 60-day money-back guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 45 reports of Cognitive disorder have been filed in association with RISANKIZUMAB-RZAA. This represents 0.1% of all adverse event reports for RISANKIZUMAB-RZAA.
45
Reports of Cognitive disorder with RISANKIZUMAB-RZAA
0.1%
of all RISANKIZUMAB-RZAA reports
2
Deaths
17
Hospitalizations
How Dangerous Is Cognitive disorder From RISANKIZUMAB-RZAA?
Of the 45 reports, 2 (4.4%) resulted in death, 17 (37.8%) required hospitalization, and 2 (4.4%) were considered life-threatening.
Is Cognitive disorder Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for RISANKIZUMAB-RZAA. However, 45 reports have been filed with the FAERS database.
What Other Side Effects Does RISANKIZUMAB-RZAA Cause?
Psoriasis (6,896)
Drug ineffective (2,885)
Pain (2,584)
Fatigue (2,483)
Arthralgia (2,419)
Pruritus (2,311)
Covid-19 (2,145)
Death (1,700)
Fall (1,666)
Surgery (1,662)
What Other Drugs Cause Cognitive disorder?
CARBIDOPA\LEVODOPA (1,449)
DIMETHYL (1,405)
NATALIZUMAB (1,309)
LEVOTHYROXINE (1,189)
FINASTERIDE (1,074)
INTERFERON BETA-1A (1,014)
MORPHINE (929)
FINGOLIMOD (919)
CARBAMAZEPINE (849)
AMITRIPTYLINE (834)
Which RISANKIZUMAB-RZAA Alternatives Have Lower Cognitive disorder Risk?
RISANKIZUMAB-RZAA vs RISDIPLAM
RISANKIZUMAB-RZAA vs RISEDRONATE
RISANKIZUMAB-RZAA vs RISEDRONIC ACID
RISANKIZUMAB-RZAA vs RISPERDAL
RISANKIZUMAB-RZAA vs RISPERDAL CONSTA